Our reputation for excellence attracts some of the best minds in the world who conduct research that has a real impact.
The Goldilocks Collar
A special collar developed by University scientists has been giving the independence back to motor neurone disease patients all over the world.
Inhibitor of oxidative DNA repair presents with a new concept for treatment of inflammation
A first-in-class OGG1 inhibitor found to decrease lung inflammation in mice and could hold the key to treating lung disorders
Promising drug for Parkinson’s disease: Study supports fast track to clinical trials
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
A new gold standard treatment for the emergency correction of warfarin-induced coagulopathy
As a result of research undertaken by the University of Sheffield between 1995-2002, a new gold standard treatment for major bleeding when using warfarin has been established.
Interleukin-1 gene biomarkers revolutionise personalised dental healthcare in the USA
Leading research carried out at the University of Sheffield on how the cytokine, interleukin-1 works in the body was used to justify the introduction of genetic testing by insurance companies for dental healthcare in the USA.
Commercial impact of a Sheffield Spin-out: Asterion Ltd
Many drugs require frequent injections, making them inconvenient, unattractive to patients and increasing the risk of infection.